Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Isagro opens R&D plant in Italy

Italian agrochemical company Isagro (Milan) has opened a research and development facility in Novora, near Milan, Italy. The centre measures some 9,400 m2, including 2,250 m2 of laboratory space, 1,370 m2 of greenhouse, and 750 m2 of manufacturing plant.  The location is at the heart of Italy’s traditional chemistry research hub, the company says.  Isagro is to invest most of its €50 million ($53 million at the current rate) planned R&D funds for the next four years in the facility.  The move is part of the company’s goal of achieving more of its own developed proprietary products towards an annual turnover for the business of €200 million ($214 million) by 2018 against the recent €150 million ($160 million). The company boats that it is following in traditions of Italian chemical and agrochemical research with funding of 10% of turnover in R&D, placing it as Italy’s principal agrochemical new active ingredient development company. It further hopes to become a pioneer in Italian R&D partnered with control of its company through innovative financial instruments to fund the research.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts